Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2020-04-01FDA Approved: LAMOTRIGINE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves the original abbreviated new drug application for lamotrigine from Zydus Pharmaceuticals USA Inc., making a generic version ava…
-
CLINICAL_TRIALS trial_result · 2020-03-27Clinical Trial Update: Characterization of Epilepsy Patients BEEP 2b [Phase 1]
Phase 1 trial update characterizing epilepsy patients in the BEEP 2b study; completed with results posted.
-
FDA approval · 2020-03-25FDA Approved: GABAPENTIN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for gabapentin submitted by Ascend Laboratories, LLC. The approval updates the generic gabapentin pr…
-
FDA approval · 2020-03-20FDA Approved: PREGABALIN — Original Application (Chartwell RX, LLC)
FDA approves Chartwell RX, LLC's original ANDA for pregabalin, establishing a generic version of the drug.
-
FDA approval · 2020-03-16FDA Approved: ETHOSUXIMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for ethosuximide submitted by Chartwell RX, LLC, under the ANDA program.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-03-16FDA Approved: ETHOSUXIMIDE — Original Application (Epic Pharma, LLC)
FDA approved Ethosuximide from Epic Pharma, LLC under an Abbreviated New Drug Application. It is approved as a generic treatment for absence…
-
FDA approval · 2020-03-12FDA Approved: ZONISAMIDE — Supplemental Application (Exelan Pharmaceuticals, Inc.)
FDA approved a supplemental application for zonisamide (Exelan Pharmaceuticals) under an ANDA.
-
FDA approval · 2020-03-12FDA Approved: VIGABATRIN — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application for Vigabatrin (Par Health USA, LLC). This action approves changes to the product as requested by th…
-
FDA approval · 2020-02-28FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2020-02-28FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for carbamazepine, allowing an additional product authorizat…
-
FDA approval · 2020-02-27FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for EPITOL (carbamazepine). This approval pertains to a supplemental filing for the product…
-
FDA approval · 2020-02-21FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Dr. Reddy's Laboratories Ltd)
The FDA approved a supplemental application for divalproex sodium from Dr. Reddy's Laboratories Ltd, indicating an update to its labeling. T…
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures [Phase 3]
A Phase 3 study evaluating the safety and tolerability of pregabalin as add-on therapy in pediatric and adult subjects with partial onset se…
-
FDA approval · 2020-02-20FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Dr. Reddy's Laboratories Ltd)
The FDA approved a supplemental application for divalproex sodium submitted by Dr. Reddy's Laboratories Ltd. This action denotes an approved…
-
FDA approval · 2020-02-14FDA Approved: TOPIRAMATE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for topiramate submitted by Upsher-Smith Laboratories, LLC, resulting in an update to the produc…
-
FDA approval · 2020-02-12FDA Approved: LAMOTRIGINE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for Lamotrigine (generic) from Endo USA, Inc. under ANDA 204158, authorizing its marketing in the Un…
-
FDA approval · 2020-02-10FDA Approved: LAMOTRIGINE EXTENDED RELEASE — Supplemental Application (Par Health USA, LLC)
The FDA approved a supplemental application for Lamotrigine Extended Release, authorizing its extended-release formulation from Par Health U…
-
FDA approval · 2020-02-07FDA Approved: LAMOTRIGINE EXTENDED-RELEASE — Supplemental Application (Par Health USA, LLC)
FDA approved a supplemental application to approve Lamotrigine Extended-Release from Par Health USA, LLC. The product's labeling covers indi…
-
CLINICAL_TRIALS trial_result · 2020-02-07Clinical Trial Update: Pilot Trial to Evaluate The Effect of Oral Methylprednisolone on Seizure Frequency in Children With Epilepsy [Phase 1, Phase 2]
A pilot clinical trial is evaluating the effect of oral methylprednisolone on seizure frequency in children with epilepsy (Phase 1/Phase 2).
-
FDA approval · 2020-02-05FDA Approved: LEVETIRACETAM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for LEVETIRACETAM from Torrent Pharmaceuticals Limited. This reflects a supplemental approval un…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Web-based Intervention to Improve Executive Functioning in Teens With Epilepsy (Epilepsy Journey) [Phase 2]
Phase 2 clinical trial evaluating a web-based intervention to improve executive functioning in teens with epilepsy has completed.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset Seizures With or Without Secondary Generalization [Phase 4]
Phase 4 trial evaluating added-on perampanel to monotherapy in adults with partial onset seizures, completed with posted results.
-
FDA approval · 2020-01-30FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' supplemental application for divalproex sodium, resulting in an approved change to the product u…
-
FDA label_change · 2020-01-29FDA Approved: LAMOTRIGINE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved a supplemental application for Lamotrigine filed by Amneal Pharmaceuticals of New York LLC, indicating changes to its label…
-
FDA approval · 2020-01-29FDA Approved: LAMOTRIGINE — Supplemental Application (Dr. Reddys Laboratories Inc.)
The FDA approved a supplemental application for Lamotrigine from Dr. Reddy's Laboratories Inc., authorizing this generic Lamotrigine product…